SEC Form 4 · accession 0001179110-15-009335
MADRIGAL PHARMACEUTICALS, INC. · MDGL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Chen Schor
Officer — President and CEO · Director
Period of report
Jun 5, 2015
Accepted (ET)
Jun 8, 2015 · 5:06 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001157601
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 5, 2015 | A | 150,000 | $0.00 | A | 300,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (Right to Buy)F2 | $2.40 | Jun 5, 2015 | A | 500,000 | A | — | Jun 5, 2025 | Common Stock | 500,000 | 500,000 | D |
Explanation of responses
- F1Represents a restricted stock grant subject to the Issuer's lapsing forfeiture right, which lapses as to 50% of the shares on June 5, 2017 and as to the remaining 50% of the shares on June 5, 2018, provided the Reporting Person remains employed by the Issuer on such date.
- F2The option vests as to 25% of the shares on June 5, 2016 and as to an additional 6.25% of the shares on the last day of each successive three-month period thereafter, provided the Reporting Person remains employed by the Issuer on such date.